Cleveland Plains Dealer: Cancer Moonshot Requires More than Money 

07/12/2024

Few challenges loom larger for humanity than the fight against cancer. Cancer is an adversary that demands an approach that harnesses the latest technology and the best instincts of the human spirit – on a global scale.

In February 2016, then-Vice President Joe Biden hosted the first meeting of the “Cancer Moonshot Task Force.” Now, he has pledged billions to realize the task force’s vision. The president’s goal of reducing mortality by 50% over the next 25 years is bold and achievable.

However, it will take more than money.

CLICK HERE to read the full column by Lamassu Biotech CEO Gabi Hanna, MD, in The Plain Dealer and Cleveland.com.

READ MORE

06/06/2025

Crain’s Cleveland Business: Cleveland biotech company secures $2.7M in NIH funding

Lamassu Biotech, a company with its “second headquarters” in Cleveland, has received a $2.7 million grant from the National Institutes of Health (NIH). The funds will help support the development of a novel treatment protocol for acute pancreatitis in canines....

06/04/2025

Cleveland Business Journal: Lamassu Biotech’s dog treatment could lead to human pancreatitis breakthrough, backed by NIH funds

Lamassu Biotech, the North Carolina-based biopharmaceutical company that opened a Cleveland office last year, has received a $2.7 million grant from the National Institutes of Health to help develop its therapy for dogs with acute pancreatitis. The therapeutic, called RABI-767, also could...

04/08/2025

The Washington Times: Biotech should take a page from Elon Musk’s playbookThe Washington Post:

Innovation has always been the foundation of progress, but how we innovate matters as much as the results we achieve. Recent breakthroughs in aerospace and artificial intelligence prove that massive budgets don’t drive innovation, but efficiency, speed and a relentless...